Aromatherapy Inhaler Use for HSCT Distress

This randomized controlled trial will evaluate the feasibility and acceptability of an inhaled aromatherapy stick for patients during the acute inpatient phase after hematopoietic cell transplantation (HCT) . The study will also explore whether aromatherapy use is associated with short-term changes in patient-reported cancer-related distress and coping self-efficacy.

NCT Number	NCT05302583
Lead Sponsor	Stanford University
Conditions	Cancer Distress, Cancer Coping, Hematopoetic Stem Cell Transplant, Aromatherapy
Enrollment	50 participants
Start Date	2025-06-16
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-12